ORASURE TECHNOLOGIES INC — Investor Relations & Filings
Filings indexed
1,018
across all filing types
Latest filing
2024-05-16
Director's Dealing
Country
US
United States of America
Listing
US
OSUR
OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | |
| 10-Q | 2024-05-09 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 11327709 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | ||
| 11327710 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | ||
| 11327711 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | ||
| 11327712 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | ||
| 11327713 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2024-05-16 | English | ||
| 11327716 | 10-Q | 2024-05-09 | English | ||
| 11327717 | 8-K | 2024-05-08 | English | ||
| 11327718 | Regulatory Filings 2024 | 2024-05-02 | English | ||
| 11327719 | Regulatory Filings 2024 | 2024-05-01 | English | ||
| 11327720 | Regulatory Filings 2024 | 2024-04-26 | English | ||
| 11327721 | 8-K | 2024-04-12 | English | ||
| 11327722 | Regulatory Filings 2024 | 2024-04-10 | English | ||
| 11327723 | DEFA14A | 2024-04-04 | English | ||
| 11327724 | ARS | 2024-04-04 | English | ||
| 11327725 | DEF 14A | 2024-04-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ORASURE TECHNOLOGIES INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33573/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33573 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33573 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33573 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33573}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ORASURE TECHNOLOGIES INC (id: 33573)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.